Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0919-2017

Drug recall · June 21, 2017

ESTRONE USP recall

Why: cGMP Deviations; lack of quality assurance.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327

Lots / codes

Lots: 052915-1, 052915-2, exp 5/5/2017

Quantity
1g=1 bottle; 5g=4 bottle; 25g=3 bottles
Company
American Pharmaceutical Ingredients LLC, Waterford, MI
Distribution
NY, GA, NV, CA, KY, TX
Initiated
April 17, 2017 · Voluntary: Firm initiated
Classified
June 15, 2017
Reported
June 21, 2017
Ended
May 31, 2018
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.